The resignation comes at a time when closing of the company’s accounts for FY22 has not been completed. In its statement to the SEC, Azure expressed inability to give a timeline for submission of its annual report on ‘Form 20-F’ for the financial year ending March 2022. “The company reiterates that it is working in close consultation with its advisers to close its annual accounts,” it said.
Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 million
Zydus Lifesciences’ shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized through a subsidiary, makes Assertio a
June 17, 2026